{
    "clinical_study": {
        "@rank": "97297", 
        "arm_group": {
            "arm_group_label": "CT scan & Early CDT Lung test", 
            "arm_group_type": "Other", 
            "description": "Every study participant receives a CT scan & Early CDT-Lung test (biomarker blood test) for lung cancer screening purposes."
        }, 
        "brief_summary": {
            "textblock": "Lung cancer is the number one cancer killer in the USA. Early stage lung cancer is\n      asymptomatic. Most patients with lung cancer are usually symptomatic at diagnosis and\n      already have advanced stage disease. Low dose CT screening (LDCT) for high risk individuals\n      has recently been shown to decrease lung cancer mortality by 20%. However, 4 out of 5 lung\n      cancer deaths are not prevented with LDCT screening alone."
        }, 
        "brief_title": "Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "High Risk of Developing Lung Cancer", 
        "condition_browse": {
            "mesh_term": "Lung Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "In this trial, the addition of a blood biomarker test is being combined with early LDCT to\n      determine if screening with combination may result in detection of more lung cancer at an\n      earlier stage of disease.The study will also assess if the blood test is able to detect lung\n      cancers in high risk individuals when the LDCT is negative for cancer. There will be\n      health-economic costs included in the final analysis of study data."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Smokers or former smokers\n\n          -  At least 20 pack year history of smoking\n\n          -  Ages 50 - 75\n\n        Exclusion Criteria:\n\n          -  Had a CT scan of chest within last 24 months\n\n          -  History of any cancer within 10 yrs (except skin cancer or cervical cancer)\n\n          -  A serious illness that decreases life expectancy to less than 5 years\n\n          -  Any current use of Oxygen\n\n          -  Uncontrolled congestive heart failure or cardiac arrhythmia that would prevent\n             surgery for a lung lesion\n\n          -  Severe COPD or dyspnea that would prevent lung surgery or stereotactic body\n             radiotherapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "1600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01700257", 
            "org_study_id": "Oncimmune-2550"
        }, 
        "intervention": [
            {
                "arm_group_label": "CT scan & Early CDT Lung test", 
                "intervention_name": "CT scan & Early CDT Lung test", 
                "intervention_type": "Radiation", 
                "other_name": [
                    "Every study participant receives a CT scan & Early CDT-Lung test (biomarker blood test)", 
                    "for lung cancer screening purposes"
                ]
            }, 
            {
                "arm_group_label": "CT scan & Early CDT Lung test", 
                "intervention_name": "CT scan & Early CDT Lung test", 
                "intervention_type": "Other", 
                "other_name": "CT scan & Early CDT-Lung test (biomarker blood test)for lung cancer screening."
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lung cancer screening", 
            "Smokers or former smokers", 
            "Family history of lung cancer"
        ], 
        "lastchanged_date": "January 28, 2014", 
        "location": {
            "contact": {
                "email": "thompsonn@njhealth.org", 
                "last_name": "Nina Thompson, BS", 
                "phone": "303-270-2564"
            }, 
            "contact_backup": {
                "email": "phillipsm@njhealth.org", 
                "last_name": "Melanie Phillips, BS", 
                "phone": "303-398-1921"
            }, 
            "facility": {
                "address": {
                    "city": "Denver", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80206"
                }, 
                "name": "National Jewish Health"
            }, 
            "investigator": {
                "last_name": "Jim Jett, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Different Strategies Using Autoantibodies and/or CT Scan Detection of Lung Cancer", 
        "other_outcome": {
            "description": "Comparison of the health economic costs of Early CDT-Lung test and CT scan when each is used individually or in combination.", 
            "measure": "Health Economics", 
            "safety_issue": "No", 
            "time_frame": "One Year"
        }, 
        "overall_contact": {
            "email": "thompsonn@njhealth.org", 
            "last_name": "Nina Thompson, BS", 
            "phone": "303-270-2564"
        }, 
        "overall_contact_backup": {
            "email": "phillipsm@njhealth.org", 
            "last_name": "Melanie Phillips, BS", 
            "phone": "303-398-1921"
        }, 
        "overall_official": {
            "affiliation": "National Jewish Health", 
            "last_name": "Jim Jett, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assess the number of lung cancers detected with CT alone vs. with both Early CDT-Lung test and CT scan. Compare positive CT results with positive/negative Early CDT Lung test results and assess ability of the combination to detect earlier stage lung cancer.", 
            "measure": "CT alone vs. both Early CDT-Lung test and CT scan.", 
            "safety_issue": "No", 
            "time_frame": "One year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01700257"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Assess the value of Early CDT-lung test in detecting lung cancer in individuals who are CT scan negative but positive for Early CDT-lung.", 
            "measure": "Value of Early CDT-lung test in detecting cancer", 
            "safety_issue": "No", 
            "time_frame": "One year"
        }, 
        "source": "National Jewish Health", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Jewish Health", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}